Skip to main content
Catherine Koss, MD, Infectious Disease, San Francisco, CA, Zuckerberg San Francisco General Hospital and Trauma Center

CatherineKossMD

Infectious Disease San Francisco, CA

Clinical Fellow, Internal Medicine, UCSF School of Medicine

Are you Dr. Koss?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 33 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Catherine Koss, MD is an infectious disease specialist in San Francisco, California. She is currently licensed to practice medicine in California. She is affiliated with Zuckerberg San Francisco General Hospital and Trauma Center and is a Clinical Fellow at UCSF School of Medicine.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Infectious Disease, 2012 - 2014
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 2009 - 2012
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 2009

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2011 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Press Mentions

  • Social Networks Key to PrEP Uptake in Rural Kenya and Uganda
    Social Networks Key to PrEP Uptake in Rural Kenya and UgandaMarch 11th, 2021
  • Universal Access to Preventive Drugs Could Reduce HIV Incidence in Sub-Saharan Africa
    Universal Access to Preventive Drugs Could Reduce HIV Incidence in Sub-Saharan AfricaFebruary 9th, 2021
  • FDA Should Help Defeat Another Viral Epidemic—HIV—by Reclassifying PrEP and PEP over the Counter
    FDA Should Help Defeat Another Viral Epidemic—HIV—by Reclassifying PrEP and PEP over the CounterJuly 9th, 2020
  • Join now to see all

Hospital Affiliations